| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| Falbikitug | AZD-0171; MSC-1 | Phase 2 Clinical | Astrazeneca Plc | Carcinoma, Non-Small-Cell Lung; Ovarian Neoplasms; Pancreatic Neoplasms; Solid tumours | Details |
| JAB-BX300 | JAB-BX300 | Phase 2 Clinical | Jacobio Pharmaceuticals Co Ltd | Pancreatic Neoplasms; Solid tumours | Details |